India Digest: Bristol Myers Squibb out of Biocon's oral insulin project; GSVlabs, Brand Capital in JV for startup accelerator

India Digest: Bristol Myers Squibb out of Biocon's oral insulin project; GSVlabs, Brand Capital in JV for startup accelerator

Ishita Russell

17 May, 2016

acceleratorBioconBrand CapitalBristol Myers SquibbGSVlabspharmaceuticals

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

Read more from India

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.